Publication:
Lp(a): Are Antithrombotic Therapies the Key to Event Reduction?

Simple item page
dc.contributor.authorDevesa, Ana
dc.contributor.authorIbáñez, Borja
dc.contributor.authorFuster, Valentin
dc.date.accessioned2023-11-22T18:23:05Z
dc.date.available2023-11-22T18:23:05Z
dc.date.issued2022-10-04
dc.description.peerreviewedSíes_ES
dc.format.number14es_ES
dc.format.page1299es_ES
dc.format.volume80es_ES
dc.identifier.citationJ Am Coll Cardiol. 2022 Oct 4;80(14):1299-1301.es_ES
dc.identifier.doi10.1016/j.jacc.2022.08.722es_ES
dc.identifier.e-issn1558-3597es_ES
dc.identifier.journalJournal of the American College of Cardiologyes_ES
dc.identifier.pubmedID36175049es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16717
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relation.publisherversion10.1016/j.jacc.2022.08.722es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Grupos de investigación::Laboratorio Traslacional para la Imagen y Terapia Cardiovasculares_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshFibrinolytic Agentses_ES
dc.subject.meshHumanses_ES
dc.titleLp(a): Are Antithrombotic Therapies the Key to Event Reduction?es_ES
dc.typeeditoriales_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication2cac8bb6-2bff-4bf6-8209-bdbd21781786
relation.isAuthorOfPublication558474d4-85be-4127-bda8-59128f707249
relation.isAuthorOfPublication.latestForDiscovery2cac8bb6-2bff-4bf6-8209-bdbd21781786

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Lp_a_Are Antithrombotic Therapies_J Am Coll Cardiol_2022.pdf
Size:
225.87 KB
Format:
Adobe Portable Document Format
Description:
Editorial Material
Download

Collections

Grupos de investigación